RxDoctor Payments Data

Jeremy Nau, PA

Physician Assistant · New Castle, PANPI 1730148636

Payments from drug & device makers

$672in general payments, 2019–2025

Across 39 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$150
  • AstraZeneca$132
  • Novartis$129
  • Amgen$103
  • Pfizer$53
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$34
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$672 in reported general payments places this provider in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$36,319
Medicare patients
264
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban540$454,072
EntrestoSacubitril/Valsartan335$293,563
XareltoRivaroxaban338$287,054
JardianceEmpagliflozin309$258,363
FarxigaDapagliflozin Propanediol85$64,640
Repatha SureclickEvolocumab54$29,610
Praluent PenAlirocumab32$15,072
Repatha PushtronexEvolocumab23$13,477
Metoprolol Succinate782$11,919
VascepaIcosapent Ethyl20$8,482
BrilintaTicagrelor16$7,812
Rosuvastatin Calcium587$7,785
Ranolazine ErRanolazine62$4,915
Atorvastatin Calcium425$4,529
Potassium Chloride166$3,306

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$53$454,072540 claims
NovartisEntresto$129$293,563335 claims
Johnson & JohnsonXarelto$150$287,054338 claims
Boehringer IngelheimJardiance$19$258,363309 claims
AstraZenecaFarxiga, Brilinta$132$72,453101 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in New Castle

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →